Hunan Er Kang Pharmaceutical (300267) — Cash Flow-to-Debt Ratio
Hunan Er Kang Pharmaceutical (300267) has a Cash Flow-to-Debt Ratio of 0.36x as of June 2023, meaning its operating cash flow of CN¥174.55 Million could theoretically repay 0% of its total liabilities (CN¥490.30 Million) in one year. See how much free cash does Hunan Er Kang Pharmaceutical generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hunan Er Kang Pharmaceutical Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Hunan Er Kang Pharmaceutical across 17 annual periods. Also explore Hunan Er Kang Pharmaceutical (300267) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year debt coverage analysis for Hunan Er Kang Pharmaceutical. For market capitalisation and broader financial context, see market cap of Hunan Er Kang Pharmaceutical.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | CN¥166.69 Million | CN¥797.54 Million | ▼ -5.8% |
| 2023 | 0.22x | CN¥148.42 Million | CN¥669.05 Million | ▼ -36.5% |
| 2022 | 0.35x | CN¥281.02 Million | CN¥804.57 Million | ▲ +110.4% |
| 2021 | 0.17x | CN¥92.68 Million | CN¥558.28 Million | ▼ -30.0% |
| 2020 | 0.24x | CN¥178.53 Million | CN¥753.22 Million | ▼ -81.4% |
| 2019 | 1.27x | CN¥445.82 Million | CN¥350.72 Million | ▲ +320.0% |
| 2018 | 0.30x | CN¥123.89 Million | CN¥409.39 Million | ▼ -86.5% |
| 2017 | 2.23x | CN¥689.11 Million | CN¥308.37 Million | ▲ +87.8% |
| 2016 | 1.19x | CN¥486.50 Million | CN¥408.94 Million | ▲ +24.7% |
| 2015 | 0.95x | CN¥518.96 Million | CN¥544.10 Million | ▲ +195.1% |
| 2014 | 0.32x | CN¥175.38 Million | CN¥542.64 Million | ▼ -79.0% |
| 2013 | 1.54x | CN¥174.22 Million | CN¥113.01 Million | ▲ +34.5% |
| 2012 | 1.15x | CN¥84.02 Million | CN¥73.32 Million | ▼ -0.3% |
| 2011 | 1.15x | CN¥75.72 Million | CN¥65.90 Million | ▲ +222.3% |
| 2010 | 0.36x | CN¥42.47 Million | CN¥119.15 Million | ▲ +165.1% |
| 2009 | 0.13x | CN¥10.18 Million | CN¥75.72 Million | ▲ +3682.9% |
| 2008 | 0.00x | CN¥211.00K | CN¥59.37 Million | — |